In the April 29, 2016, Federal Register, FDA announced it is reopening the time period for interested persons to submit comments on the public workshop initially announced in the March 9, 2016, Federal Register. As it did before, FDA seeks comments on the workshop topics concerning the use of LC/MS-based in vitro diagnostic devices in the clinical laboratory. Comments were initially requested by April 20, 2016, and the workshop was initially scheduled to take place May 2, 2016. FDA is reopening the comment period in response to requests for additional time. Comments are due June 2, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.